Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo

International Immunopharmacology

Volumn 7, Issue 9, 2007, Pages 1221-1231

  Li, Tan ^a,b   Fan, Gui Xiang ^a   Wang, Wei ^b   Li, Tong ^c   Yuan, Yu Kang ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^c Xinjiang Armed Police General Hospital   (China)

Author keywords

Apoptosis; Immunomodulation; Mouse lymphocytic leukemia; Resveratrol

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; RESVERATROL;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CD4 CD8 RATIO; CELL CYCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG MECHANISM; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEUKEMIA L 1210; LYMPHATIC LEUKEMIA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BALB 3T3 CELLS; CELL LINE, TUMOR; INTERLEUKIN-6; LEUKEMIA, LYMPHOCYTIC; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; STILBENES;

EID: 34447273318     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.05.008     Document Type: Article

References (34)

1. Fremont L. Biological effects of resveratrol. Life Sci 66 (2000) 663-673
2. Soleas G.J., Diamandis E.P., and Goldberg D.M. Resveratrol: a molecule whose time has come to gone?. Clin Biochem 30 (1997) 91-113
3. Creasy L., and Coffee M. Phytoalexin production potential of grape berries. J Am Soc Hortic Sci 113 (1988) 230-234
4. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., and Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61 (1997) 2103-2110
5. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., and Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235 (1995) 207-214
6. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
7. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004) 2783-2840
8. Aziz M.H., Kumar R., and Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 23 (2003) 17-28
9. Storch A., Burkhardt K., Ludolph A.C., Schwarz, and Johannes. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism. J Neurochem 75 (2000) 2259-2269
10. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
11. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89 (1986) 271-277
12. Si C.P. Medical immunological experiment (1999), People's Medical Publishing House, Beijing, China 21-22
13. Yang Y., Liu W., Han B., Wang C., Fu C., and Liu B. The antioxidative and immunostimulating properties of D-glucosamine. Int Immunopharmacol 7 (2007) 29-35
14. Silkworth J.B., and Loose L.D. Assessment of environmental contaminant-induced lymphocyte dysfunction. Environ Health Perspect 39 (1981) 105-128
15. Voorzanger N., Touitou R., Garcia E., Delecluse H.J., Rousset F., Joab I., et al. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 56 (1996) 5499-5505
16. Landi S., Moreno V., Gioia-Patricola L., Guino E., Navarro M., de Oca J., et al. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 63 (2003) 3560-3566
17. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
18. Ferry-Dumazet H., Garnier O., and Mamani-Matsuda M. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23 (2002) 1327-1333
19. Joe A.K., Liu H., Suzui M., Vural M.E., Xiao D., and Weinstein I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8 (2002) 893-903
20. Park J.W., Choi Y.J., and Suh S.I. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22 (2001) 1633-1639
21. Aggarwal B.B., and Shishodi S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71 (2006) 1397-1421
22. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 6 (2004) 203-208
23. Kirkin V., Joos S., and Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644 (2004) 229-249
24. Lançon A., Delma D., Osman H., Thénot J.P., Jannin B., and Latruffe N. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun 316 (2004) 1132-1137
25. Reddy L., Odhav B., and Bhoola K.D. Natural products for cancer prevention: a global perspective. Pharmacol Ther 99 (2003) 1-13
26. Clement M.V., Hirpara J.L., Vhawdhury S.H., and Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92 (1998) 996-1002
27. Maccarrone M., Lorenzon T., Guerrieri P., and Finazzi-Agrò A. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 265 (1999) 27-34
28. Kotha A., Sekharam M., Cilenti L., Siddiquee K., Khaled A., Zervos A.S., et al. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5 (2006) 621-629
29. Sun N.J., Woo S.H., Cassady J.M., and Snapka R.M. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61 (1998) 362-366
30. Schneider Y., Chabert P., Stutzmann J., Coelho D., Fougerousse A., Gosse F., et al. Resveratrol analog (Z)-3,5,4-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer 107 (2003) 189-196
31. Gao X.H., Xu Y.X., Divine G., Janakiraman N., Chapman R.A., and Gautam S.C. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 132 (2002) 2076-2081
32. Mille J.S. The biology of natural killer cells in cancer, infection, and pregnancy. Exp Hematol 29 (2001) 1157-1168
33. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 (2006) 1605-1621
34. Godoy-Ramirez K., Franck K., Mahdavifar S., Andersson L., and Gaines H. Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. J Immunol Methods 292 (2004) 1-15